{
  "question": "A 32-year-old male patient with a history of substance abuse disorder (heroin) has presented with severe toothache for the last three days. His medical history reveals he is in active treatment for substance use disorder and he has been maintaining a drug-free lifestyle for the past six months. He's currently having a severe dental abscess in the lower right second molar confirmed by dental radiography. How would you manage his condition?",
  "options": [
    "A) Prescribe opioids for pain relief",
    "B) Consult with the patient's addiction specialist before prescribing opioids for pain management",
    "C) Prescribe non-opioid analgesics and refer the patient to a dental surgeon for abscess management",
    "D) Ignore the patient's request for pain relief due to his substance abuse history"
  ],
  "context": "Dental Guideline on Prescribing Opioids for Acute Pain Management \nAdopted by the Bree Collaborative, September 27th, 2017  Page 2 of 12 \n \nCouncil on Scientific Affairs, said, \"For dental practitioners, the importance of these recommendations \nshould be carefully considered . . . Every year, millions of adolescents receive their first introduction to \nopioids following the extraction of their third molars. Many of these young adults may have never \nreceived these centrally‐acting analgesics before in their lives. We have a special responsibility to counsel \nthem about their dangers and educate them about their safe use of opioids when taken for acute \npostoperative pain.”10  \nApproximately 37% of nonmedical opioid use by high school seniors  \ncame from their leftover opioid prescription.1‐\n4 \nClinical Recommendations \nAcute pain management poses many challenges to providers regarding treatment decisions, improving \nquality of recovery, and identifying patients at risk for poor pain management or uncontrolled pain. \nAssessing patients and proposing pain management plans that minimize risk while optimizing benefits is \nincumbent on providers. Good practice involves skilled initial patient assessment, individualized pain \nmanagement strategies, effective intervention, and re‐assessment as necessary. In those rare instances \nwhen opioids are prescribed for chronic orofacial pain, providers should follow the best practices in the \nAMDG Interagency Guideline on Prescribing Opioids for Pain. \nPreoperative Period \n1. Conduct a thorough evaluation including a patient interview with dental and medical history. Screen \nfor past or current use of opioids and benzodiazepines, sedative‐hypnotics, or anxiolytics. See \nAppendix A for list of benzodiazepines, sedative‐hypnotics, and anxiolytics.  \na. Check the Prescription Monitoring Program (PMP) for every patient for whom you write a \nprescription for opioids to be aware of prior or concurrent prescriptions of opioids or sedatives. \nThis is especially critical for patients who report a history of chronic opioid or sedative use. \nPlease note, in Washington, you can delegate licensed staff in your office to check the PMP \n(AMDG Interagency Guideline on Prescribing Opioids for Pain, Appendix C: How to use the \nPrescription Monitoring Program).  \nb. Ask if the patient is currently being or has been previously prescribed chronic opioids. If so, \ncoordinate with the pain management provider before prescribing opioids.  \n2. Prescribe non‐opioid analgesics as the FIRST line of pain control for dental procedures. \na. Prescribe combinations of non‐steroidal anti‐inflammatory drugs (NSAIDs) and acetaminophen \nfollowing dental procedures where post‐operative pain is anticipated, unless there are \ncontraindications: \ni. NSAIDs contraindications include, but are not limited to: known hypersensitivity to the \ndrug, history of gastrointestinal bleeding, and aspirin sensitivity asthma.  \nDental Guideline on Prescribing Opioids for Acute Pain Management \nAdopted by the Bree Collaborative, September 27th, 2017  Page 9 of 12 \n \nAppendix C: Special Considerations for Patients \nwith Substance Use Disorder  \nPatients with substance use and/or psychiatric disorders are more likely to \nhave complications from opioid use, such as misuse, abuse or overdose.1‐\n32 \n \n1. Help patients prevent opioid misuse or relapse by prescribing opioids only when indicated, and \navoid opioids at patient request. Support patients who have made a commitment to a drug‐free \nlifestyle and take precautions when considering prescribing opioids. \n2. Use validated instruments to assess predictors of suboptimal recovery, such as depression, fear \navoidance, and catastrophizing, which can lead to persistent pain and functional limitation. \nInstruments are available here. \n3. Be knowledgeable of community resources for treatment of substance use disorders and be \nprepared to make referrals: Washington Recovery Help Line.  \n4. Complete the ADA opioid continuing education (CE) webinar and review educational materials on \nmanaging dental pain: \na. Safe Opioid Prescribing for Acute Dental Pain. Two‐hour CE class from Boston University: \nwww.opioidprescribing.com/dental. \nb. Advancing Pain Management in Oregon. Online training from the Pain Management Commission \nof the Oregon Health Authority: www.oregon.gov/oha/OHPR/PMC/Pages/index.aspx. \nc. American Dental Association statement on use of opioids in the treatment of dental pain. See \nAppendix B.  \nd. Specialists should follow additional guidelines from their specialty associations (e.g., American \nAcademy of Pediatric Dentistry, American Academy of Pediatrics, American Association of Oral \nand Maxillofacial Surgeons, American Association of Endodontists). \n5. Consult with the treating addiction specialist if the patient is in active treatment for substance use \ndisorder and coordinate before prescribing opioids. Evidence‐based care for opioid use disorder \nincludes medication‐assisted treatment (e.g., methadone, buprenorphine‐naloxone). \n6. Contact the Substance Abuse and Mental Health Services Administration (SAMHSA)’s Providers’ \nClinical Support System for Opioids (PCSS‐O) and Medication Assisted Treatment (PCSS‐MAT) for \ntreatment issues. Expert mentors are available to assist with questions or concerns about opioids \nand treatment of substance use disorders.  \n7. Support patients who are in successful long‐term recovery from a previous substance use disorder of any \nkind (e.g., alcohol, opioids, heroin, methamphetamine) and have committed to a drug‐free lifestyle. \na. Avoid “just in case” opioid prescriptions.   \nb. If severe post‐operative pain is expected, take special precautions in providing opioids. For \nexample, involve a family member, 12‐step program sponsor, or addiction counselor in \nmedication administration, and advise increasing attendance at meetings and/or counseling \nsessions during the post‐operative period.   \nDental Guideline on Prescribing Opioids for Acute Pain Management \nAdopted by the Bree Collaborative, September 27th, 2017  Page 11 of 12 \n \nReferences  \n1.  Rudd RA. Increases in Drug and Opioid‐Involved Overdose Deaths—United  States, 2010–2015. \nMorbidity and Mortality Weekly Report 2016;65. \n2.  Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription‐opioid use \nand heroin use. New England Journal of Medicine 2016;374:154‐63. \n3.  Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a \nretrospective analysis of the past 50 years. JAMA Psychiatry 2014;71:821‐6. \n4.  McCabe SE, West BT, Boyd CJ. Leftover prescription opioids and nonmedical use among high school \nseniors: a multi‐cohort national study. Journal of Adolescent Health 2013;52:480‐5. \n5.  Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription Opioid Analgesics Commonly \nUnused After Surgery: A Systematic Review. JAMA Surgery 2017. \n6.  Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions \nin 2009. JAMA 2011;305:1299‐301. \n7.  Ossiander E. Acute Opioid Prescriptions to Youth in Washington, July – December 2015. \nUnpublished Report: Washington State Department of Health; 2016. \n8.  Denisco RC, Kenna GA, O’Neil MG, Kulich RJ, Moore PA, Kane WT, Mehta NR, Hersh EV, Katz NP. \nPrevention of prescription opioid abuse: The role of the dentist. The Journal of the American Dental \nAssociation 2011;142:800‐10. \n9.  Miech R, Johnston L, O’Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and \nfuture opioid misuse. Pediatrics 2015:peds. 2015‐1364. \n10.  CDC offers new recommendations for opioids. 2016. (Accessed June 7, 2017, at \nhttp://www.ada.org/en/publications/ada‐news/2016‐archive/march/cdc‐offers‐new‐\nrecommendations‐for‐opioids. .) \n11.  Moore PA, Dionne RA, Cooper SA, Hersh EV. Why do we prescribe Vicodin? The Journal of the \nAmerican Dental Association 2016;147:530‐3. \n12.  Paulozzi LJ, Annest JL. US data show sharply rising drug‐induced death rates. Injury Prevention \n2007;13:130‐2. \n13.  Voepel‐Lewis T, Wagner D, Tait AR. Leftover prescription opioids after minor procedures: an \nunwitting source for accidental overdose in children. JAMA Pediatrics 2015;169:497‐8. \n14.  Hill MV, McMahon ML, Stucke RS, Barth Jr RJ. Wide variation and excessive dosage of opioid \nprescriptions for common general surgical procedures. Annals of Surgery 2017;265:709‐14. \n15.  Shah A. Characteristics of Initial Prescription Episodes and Likelihood of Long‐Term Opioid Use—\nUnited States, 2006–2015. Morbidity and Mortality Weekly Report 2017;66. \n16.  Dionne RA, Gordon SM, Moore PA. Prescribing Opioid Analgesics for Acute Dental Pain: Time to \nChange Clinical Practices in Response to Evidence and Misperceptions. Compendium of continuing \neducation in dentistry (Jamesburg, NJ: 1995) 2016;37:372. \n17.  Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after \nthird‐molar extractions: translating clinical research to dental practice. The Journal of the American \nDental Association 2013;144:898‐908. \n18.  Aminoshariae A, Kulild JC, Donaldson M, Hersh EV. Evidence‐based recommendations for analgesic \nefficacy to treat pain of endodontic origin: A systematic review of randomized controlled trials. The \nJournal of the American Dental Association 2016;147:826‐39. \n19.  Rodrigo M, Comfort M, Lee K. Pre‐operative diflunisal for pain relief following third molar surgery \nunder general anaesthesia. Australian Dental Journal 1993;38:125‐30. \nDental Guideline on Prescribing Opioids for Acute Pain Management \nAdopted by the Bree Collaborative, September 27th, 2017  Page 6 of 12 \n \ncontraindication for such use.18 Moderate evidence supports use of pre‐operative NSAIDs to reduce \ninflammation and post‐operative analgesic requirements.19,20 Providers should be aware that NSAIDs \nand acetaminophen also have potential for serious adverse outcomes.21,22  \nIf use of an opioid for acute pain is warranted, “clinicians should prescribe the lowest effective dose of \nimmediate‐release opioids and should prescribe no greater quantity than needed for the expected \nduration of pain severe enough to require opioids. Three days or less will often be sufficient; more than \nseven days will rarely be needed.”23 The specific recommendation for adolescents and young adults is \nbased on emerging evidence that two thirds of all patients receiving opioids for third molar extractions \nare 14 to 24 years old, there is a three‐fold variation in the amounts prescribed, and substantial \nproportions are left unused and available for subsequent misuse.4,9 Because the developing brain is at \nincreased risk for addiction, limiting opioid exposure to the shortest duration is very important in this \npopulation.24‐26 The ADA recommends reviewing the CDC recommendations for safe opioid prescribing \n(see Appendix B), and the Bree Collaborative AMDG Opioid Prescribing Guideline Implementation \nworkgroup emphasizes its importance, given the vulnerability of this population.27   \nProviders should be aware that the Food and Drug Administration approved tramadol and single‐\ningredient codeine only for use in adults. Both opioid containing products are contraindicated in \nchildren younger than 12 years due to the risk of serious breathing problems in some children with \nultra‐rapid metabolism.28 Providers should also limit use in adolescents between 12 and 18.29  \nProviders should check the Washington State Prescription Monitoring Program (PMP; also called the \nPrescription Drug Monitoring Program or PDMP in other states) for every patient before prescribing \nopioids to be certain there have been no prior or concurrent prescriptions of opioids or sedatives. This is \nstrongly recommended by both the CDC Guideline for Prescribing Opioids for Chronic Pain and by the \nAMDG Interagency Guideline on Prescribing Opioids for Pain.23,30 Per McCauley et al, “a notable minority \nof dental patients had incidents of multiple preexisting opioid prescriptions, a factor implicated in patient \nmisuse, abuse, overdose and diversion.”31 Recent data suggests that in New York, which has \nimplemented a mandatory PDMP program, there have been substantial reductions in opioid \nprescriptions and increases in non‐opioid analgesic therapy among dental prescribers. Among patients \nreceiving pain medications in dental practice, 30.6% received an opioid prior to mandatory PMP \nimplementation, while this number dropped to 14.1% and 9.6% in the two three‐month periods \nfollowing implementation.25 This recommendation is also consistent with the ADA February 2017 \nStatement on the Use of Opioids in the Treatment of Dental Pain: “Dentists should register with and \nutilize the prescription drug monitoring program to promote the appropriate use of controlled \nsubstances for legitimate medical purposes, while deterring the misuse, abuse and diversion of these \nsubstances.”27 See Appendix B for the full list of ADA recommendations. \n   ",
  "experiments": {
    "chain_of_thought": {
      "method": "Chain-of-thought reasoning",
      "response": "Reasoning Chain:\n1. The patient is a 32-year-old male with a history of substance abuse disorder (heroin) and is currently in active treatment for substance use disorder. He has been maintaining a drug-free lifestyle for the past six months. He is presenting with severe toothache due to a dental abscess in the lower right second molar.\n2. The Dental Guideline on Prescribing Opioids for Acute Pain Management advises against prescribing opioids for patients with a history of substance abuse disorder. It recommends prescribing non-opioid analgesics as the first line of pain control for dental procedures. It also suggests consulting with the patient's addiction specialist before prescribing opioids.\n3. Evaluating the options, prescribing opioids (Option A) is not recommended due to the patient's history of substance abuse. Ignoring the patient's request for pain relief (Option D) is not ethical or appropriate. Consulting with the patient's addiction specialist before prescribing opioids (Option B) is a good practice, but prescribing opioids should be avoided if possible. Prescribing non-opioid analgesics and referring the patient to a dental surgeon for abscess management (Option C) aligns with the guidelines and the patient's specific situation.\n\nFinal Answer: C\nConfidence: High\nJustification: Option C is the most appropriate as it aligns with the guidelines provided in the context. It avoids the use of opioids, which could potentially trigger a relapse in the patient's substance abuse disorder, and ensures the patient's dental issue is addressed by referring him to a dental surgeon."
    },
    "tree_of_thought": {
      "method": "Tree-of-thought reasoning",
      "response": "Path 1 (Safety) Analysis:\nOption A (prescribing opioids) poses a significant risk due to the patient's history of substance abuse. Option D (ignoring the patient's request for pain relief) is not safe or ethical as it neglects the patient's immediate need for pain management. Options B and C are safer as they either involve consultation with the patient's addiction specialist or avoid opioids altogether.\n\nPath 2 (Guidelines) Analysis:\nThe guidelines clearly state that non-opioid analgesics should be the first line of pain control for dental procedures. They also recommend consulting with the treating addiction specialist if the patient is in active treatment for substance use disorder. Therefore, options B and C align with the guidelines, while options A and D do not.\n\nPath 3 (Patient-Specific) Analysis:\nGiven the patient's history of substance abuse and current drug-free lifestyle, prescribing opioids (option A) could potentially trigger a relapse. Ignoring the patient's request for pain relief (option D) is not patient-centered and could lead to further complications. Consulting with the patient's addiction specialist (option B) or prescribing non-opioid analgesics (option C) are more considerate of the patient's specific circumstances.\n\nCombined Decision:\nFinal Answer: C\nConfidence: High\nJustification: Option C (prescribing non-opioid analgesics and referring the patient to a dental surgeon for abscess management) is the safest and most appropriate choice. It aligns with the guidelines, manages the patient's pain effectively, and respects the patient's commitment to a drug-free lifestyle."
    },
    "structured_medical": {
      "method": "Structured medical reasoning (SOAP)",
      "response": "Subjective:\n- Chief complaint: A 32-year-old male patient presents with severe toothache for the last three days.\n- Relevant history: The patient has a history of substance abuse disorder (heroin) and is currently in active treatment for substance use disorder. He has been maintaining a drug-free lifestyle for the past six months.\n- Patient's current situation: He's currently having a severe dental abscess in the lower right second molar confirmed by dental radiography.\n\nObjective:\n- Key findings from the case: The patient has a severe dental abscess and a history of substance abuse disorder.\n- Relevant data from context: The Dental Guideline on Prescribing Opioids for Acute Pain Management recommends prescribing non-opioid analgesics as the first line of pain control for dental procedures. It also suggests consulting with the treating addiction specialist if the patient is in active treatment for substance use disorder before prescribing opioids.\n- Evidence-based guidelines applicable: The guidelines suggest that opioids should be avoided in patients with a history of substance abuse disorder, and non-opioid analgesics should be the first line of treatment.\n\nAssessment:\n- Analysis of the medical situation: The patient is in pain due to a dental abscess and needs pain management. However, his history of substance abuse disorder complicates the situation.\n- Evaluation of each treatment option: Prescribing opioids (Option A) is not recommended due to the patient's history of substance abuse. Ignoring the patient's request for pain relief (Option D) is not ethical or medically appropriate. Consulting with the patient's addiction specialist before prescribing opioids (Option B) is a good practice, but prescribing opioids should still be avoided if possible. Prescribing non-opioid analgesics and referring the patient to a dental surgeon for abscess management (Option C) aligns with the guidelines and seems to be the most appropriate option.\n- Risk-benefit analysis: The risk of relapse into substance abuse with opioid prescription is high, while the benefit of pain relief can be achieved with non-opioid analgesics. The benefit of treating the abscess outweighs the minimal risk associated with dental surgery.\n\nPlan:\nFinal Answer: C\nConfidence: High\nJustification: Prescribing non-opioid analgesics and referring the patient to a dental surgeon for abscess management aligns with the guidelines for patients with a history of substance abuse disorder. This approach provides pain relief and treats the underlying cause of the pain without risking a potential relapse into substance abuse."
    }
  }
}